Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 10/2010

Ausgabe 10/2010

Inhaltsverzeichnis ( 19 Artikel )

01.10.2010 | Review | Ausgabe 10/2010

Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?

Stanisław Szala, Iwona Mitrus, Aleksander Sochanik

01.10.2010 | Original Article | Ausgabe 10/2010

Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients

Kazuko Uno, Kiyotaka Okuno, Takuma Kato, Saeko Tada-Oikawa, Norimichi Kan, Hideo Saotome, Katsumi Yagi, Junji Hamuro

01.10.2010 | Original Article | Ausgabe 10/2010

WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer

Lee M. Krug, Tao Dao, Andrew B. Brown, Peter Maslak, William Travis, Sara Bekele, Tatyana Korontsvit, Victoria Zakhaleva, Jedd Wolchok, Jianda Yuan, Hao Li, Leslie Tyson, David A. Scheinberg

01.10.2010 | Original Article | Ausgabe 10/2010

Identification and characterization of Ch806 mimotopes

Lin Yang, Hua Jiang, Bizhi Shi, Huamao Wang, Jinjun Li, Hai Wang, Ming Yao, Zonghai Li

01.10.2010 | Original Article | Ausgabe 10/2010 Open Access

Response definition criteria for ELISPOT assays revisited

Z. Moodie, L. Price, C. Gouttefangeas, A. Mander, S. Janetzki, M. Löwer, M. J. P. Welters, C. Ottensmeier, S. H. van der Burg, Cedrik M. Britten

01.10.2010 | Original Article | Ausgabe 10/2010

The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer

Kouichi Kobayashi, Yuriko Tanaka, Shigetoshi Horiguchi, Shouji Yamamoto, Nakayama Toshinori, Akira Sugimoto, Yoshitaka Okamoto

01.10.2010 | Original Article | Ausgabe 10/2010

Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study

Shimon Slavin, Aliza Ackerstein, Reuven Or, Michael Y. Shapira, Benjamin Gesundheit, Nadir Askenasy, Shoshana Morecki

01.10.2010 | Original Article | Ausgabe 10/2010

Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors

Jaafar Bennouna, Vincent Levy, Hélène Sicard, Hélène Senellart, Marie Audrain, Sandrine Hiret, Frédéric Rolland, Heriberto Bruzzoni-Giovanelli, Marie Rimbert, Céline Galéa, Jérome Tiollier, Fabien Calvo

01.10.2010 | Original Article | Ausgabe 10/2010

A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer

Yuki Masuda, Koichi Ito, Morichika Konishi, Hiroaki Nanba

01.10.2010 | Original Article | Ausgabe 10/2010

CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection

Noriyuki Yamada, Satoshi Oizumi, Eiki Kikuchi, Naofumi Shinagawa, Jun Konishi-Sakakibara, Atsushi Ishimine, Keisuke Aoe, Kenichi Gemba, Takumi Kishimoto, Toshihiko Torigoe, Masaharu Nishimura

01.10.2010 | Original Article | Ausgabe 10/2010

Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion

Stephanie L. Goff, Laura A. Johnson, Mary A. Black, Hui Xu, Zhili Zheng, Cyrille J. Cohen, Richard A. Morgan, Steven A. Rosenberg, Steven A. Feldman

01.10.2010 | Original Article | Ausgabe 10/2010

CD8+ T cell recognition of polymorphic wild-type sequence p5365–73 peptides in squamous cell carcinoma of the head and neck

Pedro A. Andrade Filho, Daisuke Ito, Albert B. DeLeo, Robert L. Ferris

01.10.2010 | Meeting Report | Ausgabe 10/2010

Ninth international conference on progress in vaccination against cancer (PIVAC 9), 8–10 October 2009, Sofia, Bulgaria

Elissaveta Naumova, Stéphanie McArdle, Graham Pawelec

01.10.2010 | Focussed Research Review | Ausgabe 10/2010

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Gerty Schreibelt, Jurjen Tel, Kwinten H. E. W. J. Sliepen, Daniel Benitez-Ribas, Carl G. Figdor, Gosse J. Adema, I. Jolanda M. de Vries

01.10.2010 | Focussed Research Review | Ausgabe 10/2010

DNA vaccination strategies for anti-tumour effective gene therapy protocols

Emanuela Signori, Sandra Iurescia, Emanuela Massi, Daniela Fioretti, Pieranna Chiarella, Mariangela De Robertis, Monica Rinaldi, Giancarlo Tonon, Vito Michele Fazio

01.10.2010 | Focussed Research Review | Ausgabe 10/2010

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

Suzanne Ostrand-Rosenberg

01.10.2010 | Focussed Research Review | Ausgabe 10/2010

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions

Federico Garrido, Ignacio Algarra, Angel M. García-Lora

01.10.2010 | Letter to the editor | Ausgabe 10/2010

Cetuximab-dependent ADCC in cancer: dream or reality?

Alessandro Ottaiano, Stefania Scala, Vincenzo Rosario Iaffaioli

01.10.2010 | Letter to the editor | Ausgabe 10/2010

Response to the letter to the editors by Ottaiano et al.: “Cetuximab-dependent ADCC in cancer: dream or reality?”

Robert L. Ferris, Soldano Ferrone

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise